Canada markets closed

BriaCell Therapeutics Corp. (BCTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.47-0.01 (-0.13%)
At close: 04:00PM EST
7.58 +0.11 (+1.47%)
After hours: 04:59PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 117.47M
Enterprise Value 62.00M
Trailing P/E 753.00
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)11.31
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -156.31

Trading Information

Stock Price History

Beta (5Y Monthly) 1.38
52-Week Change 313.73%
S&P500 52-Week Change 3-12.46%
52 Week High 312.09
52 Week Low 34.06
50-Day Moving Average 35.84
200-Day Moving Average 36.15

Share Statistics

Avg Vol (3 month) 3230.46k
Avg Vol (10 day) 3305.67k
Shares Outstanding 515.52M
Implied Shares Outstanding 6N/A
Float 811.41M
% Held by Insiders 123.70%
% Held by Institutions 116.10%
Shares Short (Jan 12, 2023) 41.31M
Short Ratio (Jan 12, 2023) 45.84
Short % of Float (Jan 12, 2023) 49.75%
Short % of Shares Outstanding (Jan 12, 2023) 48.41%
Shares Short (prior month Dec 14, 2022) 41.4M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 01, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:300
Last Split Date 3Jan 01, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2022
Most Recent Quarter (mrq)Oct 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.32%
Return on Equity (ttm)-6.91%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -18.39M
Net Income Avi to Common (ttm)-411.96k
Diluted EPS (ttm)0.01
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)37.45M
Total Cash Per Share (mrq)2.41
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)39.24
Book Value Per Share (mrq)0.67

Cash Flow Statement

Operating Cash Flow (ttm)-14.25M
Levered Free Cash Flow (ttm)-7.62M